[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-001", "question": "A 68-year-old man with metastatic castration-resistant prostate cancer (mCRPC) on enzalutamide presents with progressive dyspnea and fatigue. He has no chest pain or fever. His oxygen saturation is 88% on room air. CT pulmonary angiography shows no pulmonary embolism, but reveals diffuse ground-glass opacities with peripheral sparing. Bronchoalveolar lavage shows lymphocytic predominance with CD4:CD8 ratio of 0.3. Which of the following is the most appropriate next step in management?", "options": ["Discontinue enzalutamide and initiate high-dose corticosteroids", "Initiate empiric broad-spectrum antibiotics for atypical pneumonia", "Add abiraterone to his current regimen and continue enzalutamide", "Perform transbronchial biopsy to rule out lymphangitic carcinomatosis", "Start therapeutic-dose low-molecular-weight heparin for occult pulmonary embolism"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for enzalutamide-induced interstitial pneumonitis, which typically presents with subacute dyspnea, ground-glass opacities on CT, and a lymphocytic BAL with low CD4:CD8 ratio. Immediate discontinuation of the offending agent and initiation of corticosteroids is the standard management. Antibiotics are not indicated without infectious signs, and adding abiraterone would exacerbate the drug-induced lung injury.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. The keyed answer is correct and uniquely defensible. Critical stem clues—enzalutamide exposure, progressive dyspnea with hypoxia, diffuse ground-glass opacities, lymphocytic BAL with low CD4:CD8 ratio (0.3), and absence of infectious signs—collectively point to drug-induced interstitial pneumonitis. Standard management requires immediate drug discontinuation and high-dose corticosteroids, making option A the single best next step. Options B, C, D, and E are appropriately excluded: antibiotics lack indication; adding abiraterone would compound injury; biopsy is unnecessary when the clinical picture is diagnostic; anticoagulation is contraindicated by negative CTPA. No internal contradictions exist. Medical accuracy is strong (score 4/5): enzalutamide-induced pneumonitis is a recognized toxicity, and the management aligns with current consensus. Minor issue: 'peripheral sparing' is an atypical descriptor for drug-induced pneumonitis, though not erroneous enough to invalidate the item. Minimal fix: revise CT description to 'diffuse ground-glass opacities' without specifying distribution, ensuring radiographic pattern matches typical drug-induced injury.\",\"medical_accuracy_score\":4,\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The keyed answer is correct and uniquely defensible. Critical stem clues—enzalutamide exposure, progressive dyspnea with hypoxia, diffuse ground-glass opacities, lymphocytic BAL with low CD4:CD8 ratio (0.3), and absence of infectious signs—collectively point to drug-induced interstitial pneumonitis. Standard management requires immediate drug discontinuation and high-dose corticosteroids, making option A the single best next step. Options B, C, D, and E are appropriately excluded: antibiotics lack indication; adding abiraterone would compound injury; biopsy is unnecessary when the clinical picture is diagnostic; anticoagulation is contraindicated by negative CTPA. No internal contradictions exist. Medical accuracy is strong (score 4/5): enzalutamide-induced pneumonitis is a recognized toxicity, and the management aligns with current consensus. Minor issue: 'peripheral sparing' is an atypical descriptor for drug-induced pneumonitis, though not erroneous enough to invalidate the item. Minimal fix: revise CT description to 'diffuse ground-glass opacities' without specifying distribution, ensuring radiographic pattern matches typical drug-induced injury.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-002", "question": "A 4-month-old previously healthy infant presents with acute onset of irritability, vomiting, and lethargy. Physical examination reveals a bulging anterior fontanelle, retinal hemorrhages, and no focal neurologic deficits. Non-contrast head CT shows bilateral subdural hematomas of different ages. The infant's coagulation studies and metabolic panel are normal. Which of the following additional findings would most strongly support a diagnosis of glutaric aciduria type 1 rather than non-accidental trauma?", "options": ["Metaphyseal corner fractures on skeletal survey", "Elevated serum ammonia level", "Frontotemporal atrophy with widened Sylvian fissures on MRI", "Subarachnoid hemorrhage extending into the posterior fossa", "Elevated urine organic acids showing 3-hydroxyglutaric aciduria"], "answer": "E", "answer_index": 4, "explanation": "While glutaric aciduria type 1 can mimic non-accidental trauma with acute encephalopathy and subdural hematomas, the definitive diagnosis requires demonstration of elevated urine organic acids, specifically 3-hydroxyglutaric aciduria. Frontotemporal atrophy (option C) is a characteristic neuroimaging finding but is not diagnostic. Metaphyseal fractures strongly suggest abuse, while elevated ammonia suggests a different metabolic disorder.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. The vignette describes a 4-month-old with acute encephalopathy, bilateral subdural hematomas of different ages, retinal hemorrhages, and bulging fontanelle—features that overlap between glutaric aciduria type 1 (GA-1) and non-accidental trauma (NAT). The question asks which finding most strongly supports GA-1 over NAT. Key discriminating clues are sought. Option E (elevated urine 3-hydroxyglutaric aciduria) represents the definitive biochemical diagnostic test for GA-1, directly distinguishing it from NAT. Option C (frontotemporal atrophy with widened Sylvian fissures) is a characteristic neuroimaging feature of GA-1 but is not pathognomonic and can be seen in other conditions, making it less definitive. Options A (metaphyseal fractures) and B (elevated ammonia) point toward alternative diagnoses (abuse and other metabolic disorders, respectively). Option D is nonspecific. The keyed answer is uniquely best, logically supported, and medically accurate. No contradictions or critical missing details exist. Medical accuracy is excellent, reflecting current consensus that GA-1 can mimic NAT and requires specific biochemical testing for definitive diagnosis. Minimal fix: None required; item is well-constructed and board-ready.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. The vignette describes a 4-month-old with acute encephalopathy, bilateral subdural hematomas of different ages, retinal hemorrhages, and bulging fontanelle—features that overlap between glutaric aciduria type 1 (GA-1) and non-accidental trauma (NAT). The question asks which finding most strongly supports GA-1 over NAT. Key discriminating clues are sought. Option E (elevated urine 3-hydroxyglutaric aciduria) represents the definitive biochemical diagnostic test for GA-1, directly distinguishing it from NAT. Option C (frontotemporal atrophy with widened Sylvian fissures) is a characteristic neuroimaging feature of GA-1 but is not pathognomonic and can be seen in other conditions, making it less definitive. Options A (metaphyseal fractures) and B (elevated ammonia) point toward alternative diagnoses (abuse and other metabolic disorders, respectively). Option D is nonspecific. The keyed answer is uniquely best, logically supported, and medically accurate. No contradictions or critical missing details exist. Medical accuracy is excellent, reflecting current consensus that GA-1 can mimic NAT and requires specific biochemical testing for definitive diagnosis. Minimal fix: None required; item is well-constructed and board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-003", "question": "A 55-year-old woman with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who failed CAR T-cell therapy 3 months ago presents with new-onset confusion and myoclonus. MRI brain shows symmetric diffusion restriction in the bilateral thalami, basal ganglia, and cerebral cortex. EEG demonstrates periodic sharp wave complexes. CSF shows 12 white cells/mm³ (90% lymphocytes), normal glucose, and elevated protein at 80 mg/dL. Which of the following is the most likely causative agent?", "options": ["Tafasitamab", "Polatuzumab vedotin", "Tisagenlecleucel", "Blinatumomab", "Brentuximab vedotin"], "answer": "C", "answer_index": 2, "explanation": "This presentation is classic for CAR T-cell therapy-related immune effector cell-associated neurotoxicity syndrome (ICANS), which can occur weeks to months after treatment. The MRI pattern of symmetric deep gray matter and cortical involvement with corresponding EEG findings is characteristic. Tisagenlecleucel is a CD19-directed CAR T-cell therapy used in DLBCL. The other agents are monoclonal antibodies or antibody-drug conjugates not typically associated with this specific delayed neurotoxicity pattern.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: C (Contradiction). The vignette describes symmetric diffusion restriction in thalami/basal ganglia/cortex with periodic sharp wave complexes on EEG—findings pathognomonic for Creutzfeldt-Jakob disease, not CAR T-cell neurotoxicity (ICANS). ICANS occurs acutely within days to weeks post-infusion, not 3 months later, and presents with encephalopathy/aphasia plus non-specific T2 hyperintensities, not delayed symmetric diffusion restriction. The CSF profile is non-specific but fits prion disease. Consequently, none of the listed agents can plausibly cause this syndrome, making the item unsolvable. The keyed answer C (tisagenlecleucel) is fundamentally miskeyed because the described syndrome is inconsistent with ICANS pathophysiology and timeline. This represents a dangerous medical inaccuracy that would mislead learners about neurotoxicity syndromes. The stem facts directly contradict the intended teaching point. Minimal fix: Revise neuroimaging/EEG to reflect authentic ICANS features (e.g., early-onset T2 hyperintensities within 2 weeks) or reframe the question as prion disease with appropriate risk factors and remove the CAR-T history entirely.\",\"medical_accuracy_score\":1,\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). The vignette describes symmetric diffusion restriction in thalami/basal ganglia/cortex with periodic sharp wave complexes on EEG—findings pathognomonic for Creutzfeldt-Jakob disease, not CAR T-cell neurotoxicity (ICANS). ICANS occurs acutely within days to weeks post-infusion, not 3 months later, and presents with encephalopathy/aphasia plus non-specific T2 hyperintensities, not delayed symmetric diffusion restriction. The CSF profile is non-specific but fits prion disease. Consequently, none of the listed agents can plausibly cause this syndrome, making the item unsolvable. The keyed answer C (tisagenlecleucel) is fundamentally miskeyed because the described syndrome is inconsistent with ICANS pathophysiology and timeline. This represents a dangerous medical inaccuracy that would mislead learners about neurotoxicity syndromes. The stem facts directly contradict the intended teaching point. Minimal fix: Revise neuroimaging/EEG to reflect authentic ICANS features (e.g., early-onset T2 hyperintensities within 2 weeks) or reframe the question as prion disease with appropriate risk factors and remove the CAR-T history entirely.", "medical_accuracy_score": 1, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 1}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-004", "question": "A critically ill patient with septic shock on norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) develops refractory hypotension. Transthoracic echocardiogram shows a hyperdynamic left ventricle with collapsing mitral inflow pattern. Which of the following interventions is most likely to improve hemodynamics without increasing myocardial oxygen demand?", "options": ["Initiate dobutamine infusion at 5 mcg/kg/min", "Add phenylephrine infusion to target MAP >65 mmHg", "Administer 500 mL 5% albumin bolus", "Start angiotensin II infusion at 20 ng/kg/min", "Increase norepinephrine to 0.5 mcg/kg/min"], "answer": "D", "answer_index": 3, "explanation": "The echocardiographic findings suggest distributive shock with relative hypovolemia. Angiotensin II acts via AT1 receptors to cause vasoconstriction without significant inotropic effects, making it ideal for this scenario without increasing myocardial oxygen demand. Dobutamine increases myocardial demand, phenylephrine causes pure alpha-agonism with potential reflex bradycardia, fluid bolus may be insufficient in vasoplegic shock, and increasing norepinephrine adds beta-1 effects that increase oxygen consumption.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"The stem describes a patient with septic shock refractory to norepinephrine and vasopressin, hyperdynamic LV, and a collapsing mitral inflow pattern, suggesting low preload and severe vasodilation. The question asks for the intervention most likely to improve hemodynamics without increasing myocardial oxygen demand. Options include fluid bolus (albumin), additional vasoconstrictors (phenylephrine, angiotensin II), and inotropes (dobutamine, increased norepinephrine). The keyed answer is angiotensin II, justified by its pure vasoconstrictor action and minimal inotropic effect. However, the explanation contains a logical contradiction: it acknowledges ‘relative hypovolemia’ yet recommends a vasoconstrictor over fluid, and it incorrectly claims that angiotensin II does not increase myocardial oxygen demand (increased afterload can raise demand). Both fluid bolus (addressing the low preload) and angiotensin II (addressing vasodilation) are defensible best answers, but the stem does not specify whether the patient has received adequate fluid resuscitation or is fluid‑unresponsive. This ambiguity makes more than one option equally plausible, violating the single‑best‑answer requirement. The item is therefore logically invalid (multiple answers defensible). A minimal fix would be to add a line stating that the patient has already received 30 mL/kg of fluid and remains hypotensive with persistent low preload, making a vasoconstrictor the next step.\",\n\"medical_accuracy_score\": 3,\n\"logical_validity\": false,\n\"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The stem describes a patient with septic shock refractory to norepinephrine and vasopressin, hyperdynamic LV, and a collapsing mitral inflow pattern, suggesting low preload and severe vasodilation. The question asks for the intervention most likely to improve hemodynamics without increasing myocardial oxygen demand. Options include fluid bolus (albumin), additional vasoconstrictors (phenylephrine, angiotensin II), and inotropes (dobutamine, increased norepinephrine). The keyed answer is angiotensin II, justified by its pure vasoconstrictor action and minimal inotropic effect. However, the explanation contains a logical contradiction: it acknowledges ‘relative hypovolemia’ yet recommends a vasoconstrictor over fluid, and it incorrectly claims that angiotensin II does not increase myocardial oxygen demand (increased afterload can raise demand). Both fluid bolus (addressing the low preload) and angiotensin II (addressing vasodilation) are defensible best answers, but the stem does not specify whether the patient has received adequate fluid resuscitation or is fluid‑unresponsive. This ambiguity makes more than one option equally plausible, violating the single‑best‑answer requirement. The item is therefore logically invalid (multiple answers defensible). A minimal fix would be to add a line stating that the patient has already received 30 mL/kg of fluid and remains hypotensive with persistent low preload, making a vasoconstrictor the next step.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-005", "question": "A 7-year-old boy presents with acute cerebellar ataxia following varicella infection 2 weeks prior. MRI shows T2 hyperintensity restricted to the cerebellar hemispheres. CSF demonstrates 15 lymphocytes/mm³, normal glucose, and elevated IgG index. Which of the following autoantibodies is most specific for this condition?", "options": ["Anti-GAD65", "Anti-Hu", "Anti-Yo", "Anti-Tr/DNER", "Anti-mGluR1"], "answer": "D", "answer_index": 3, "explanation": "Post-varicella acute cerebellar ataxia is associated with anti-Tr/DNER (delta/notch-like epidermal growth factor-related receptor) antibodies in a significant proportion of cases. This antibody is highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma but also occurs in post-infectious contexts. Anti-Yo and anti-Hu are associated with gynecological/breast cancers and small cell lung cancer respectively. Anti-mGluR1 is seen in Hodgkin-related ataxia, while anti-GAD65 is associated with stiff-person syndrome.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). The stem presents a 7-year-old boy with acute cerebellar ataxia two weeks after varicella infection, MRI showing isolated cerebellar T2 hyperintensity, and CSF with mild lymphocytic pleocytosis and an elevated IgG index. This constellation is typical of post-infectious cerebellitis. The question asks for the most specific autoantibody for this condition. Among the options, anti‑Tr/DNER is the only antibody that has been reported in post‑varicella cerebellar ataxia; it is also the hallmark of paraneoplastic cerebellar degeneration in Hodgkin lymphoma, but it appears in post‑infectious contexts as well. Anti‑Yo and anti‑Hu are linked to gynecologic and small‑cell lung cancers, anti‑mGluR1 to Hodgkin‑related ataxia, and anti‑GAD65 to stiff‑person syndrome—none of which are specific to this scenario. Consequently, a single best answer is clearly defensible, and the provided key matches it. No internal contradictions or missing critical details are present. Medical accuracy aligns with current literature, although anti‑Tr/DNER is not absolutely exclusive to varicella‑associated ataxia, it remains the most specific choice offered. No revision is needed.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The stem presents a 7-year-old boy with acute cerebellar ataxia two weeks after varicella infection, MRI showing isolated cerebellar T2 hyperintensity, and CSF with mild lymphocytic pleocytosis and an elevated IgG index. This constellation is typical of post-infectious cerebellitis. The question asks for the most specific autoantibody for this condition. Among the options, anti‑Tr/DNER is the only antibody that has been reported in post‑varicella cerebellar ataxia; it is also the hallmark of paraneoplastic cerebellar degeneration in Hodgkin lymphoma, but it appears in post‑infectious contexts as well. Anti‑Yo and anti‑Hu are linked to gynecologic and small‑cell lung cancers, anti‑mGluR1 to Hodgkin‑related ataxia, and anti‑GAD65 to stiff‑person syndrome—none of which are specific to this scenario. Consequently, a single best answer is clearly defensible, and the provided key matches it. No internal contradictions or missing critical details are present. Medical accuracy aligns with current literature, although anti‑Tr/DNER is not absolutely exclusive to varicella‑associated ataxia, it remains the most specific choice offered. No revision is needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-006", "question": "A 42-year-old woman with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) achieves complete morphological remission after induction chemotherapy. Minimal residual disease (MRD) testing by flow cytometry shows 0.01% blasts. Which of the following factors would most strongly indicate proceeding to allogeneic hematopoietic stem cell transplantation in first complete remission rather than continuing with chemotherapy plus a tyrosine kinase inhibitor?", "options": ["Presence of IKZF1 deletion", "Age >40 years", "MRD positivity after consolidation therapy", "White blood cell count >30,000/μL at diagnosis", "Presence of additional cytogenetic abnormalities besides t(9;22)"], "answer": "C", "answer_index": 2, "explanation": "In Ph+ ALL, MRD positivity after consolidation therapy is the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for allogeneic transplantation in first remission. While age >40, high WBC, IKZF1 deletion, and additional abnormalities are adverse prognostic factors, contemporary TKI-based regimens can overcome many of these. Persistent MRD after intensive therapy indicates resistant disease requiring transplant for cure.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). The item asks which factor most strongly indicates allogeneic transplant in Ph+ ALL in first CR. The keyed answer, MRD positivity after consolidation, is widely recognized as the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for transplant. The stem notes MRD 0.01% after induction, which is positive, but the question is framed conceptually, not requiring the answer to be present in the vignette. All other options (IKZF1 deletion, age >40, high WBC, additional cytogenetic abnormalities) are adverse prognostic factors but are less decisive than MRD persistence after consolidation in modern TKI-era regimens. No internal contradictions exist; the options are distinct and permit a single best choice. Medical accuracy is high: the answer aligns with current NCCN/ELN guidelines and recent trial data (e.g., GIMEMA, UKALLXII). The only minor weakness is that the stem mentions MRD after induction while the answer refers to post‑consolidation MRD; a minimal fix would be to add a phrase such as 'after completion of consolidation therapy' to the stem to align the scenario with the answer. Overall, the item is sound and the key is correct.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). The item asks which factor most strongly indicates allogeneic transplant in Ph+ ALL in first CR. The keyed answer, MRD positivity after consolidation, is widely recognized as the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for transplant. The stem notes MRD 0.01% after induction, which is positive, but the question is framed conceptually, not requiring the answer to be present in the vignette. All other options (IKZF1 deletion, age >40, high WBC, additional cytogenetic abnormalities) are adverse prognostic factors but are less decisive than MRD persistence after consolidation in modern TKI-era regimens. No internal contradictions exist; the options are distinct and permit a single best choice. Medical accuracy is high: the answer aligns with current NCCN/ELN guidelines and recent trial data (e.g., GIMEMA, UKALLXII). The only minor weakness is that the stem mentions MRD after induction while the answer refers to post‑consolidation MRD; a minimal fix would be to add a phrase such as 'after completion of consolidation therapy' to the stem to align the scenario with the answer. Overall, the item is sound and the key is correct.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-007", "question": "A 65-year-old man with atrial fibrillation on apixaban presents with acute onset of aphasia and right hemiparesis. CT head shows a 3 cm left MCA territory infarct with no hemorrhage. Last apixaban dose was 4 hours ago. NIH Stroke Scale is 18. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator immediately", "Give 4-factor prothrombin complex concentrate followed by tPA", "Perform emergent mechanical thrombectomy without thrombolysis", "Administer andexanet alfa followed by mechanical thrombectomy", "Give idarucizumab empirically followed by mechanical thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "For large vessel occlusion strokes in patients on direct oral anticoagulants (DOACs) with recent dosing, mechanical thrombectomy without thrombolysis is recommended due to the increased risk of hemorrhagic transformation with tPA. Andexanet alfa is a reversal agent for factor Xa inhibitors but is not routinely recommended prior to thrombectomy unless there is life-threatening bleeding. Idarucizumab is for dabigatran reversal. PCC before tPA still carries bleeding risk and delays intervention.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. The vignette describes an acute large-vessel occlusion stroke (NIHSS 18, aphasia, right hemiparesis) in a patient on apixaban 4 hours prior, making IV tPA contraindicated per AHA/ASA guidelines. Mechanical thrombectomy without thrombolysis (C) is the uniquely defensible best answer for LVO when tPA is contraindicated. Option A is contraindicated due to recent DOAC use. Option B is not standard practice and still carries hemorrhage risk. Option D (andexanet) is not routinely recommended before thrombectomy unless life-threatening bleeding occurs and would delay reperfusion. Option E (idarucizumab) is specific for dabigatran reversal and ineffective for apixaban. The item is medically accurate and aligns with current stroke guidelines. Minor limitation: the stem does not explicitly confirm LVO with CTA, though NIHSS 18 strongly implies it; specifying 'CTA-confirmed M1 occlusion' would eliminate any ambiguity. No contradictions or underspecification that prevents selecting a single best answer. The teaching point correctly prioritizes rapid reperfusion while respecting anticoagulation contraindications. Overall, a high-quality, board-style item that tests a critical management decision.\",\"medical_accuracy_score\":4,\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The vignette describes an acute large-vessel occlusion stroke (NIHSS 18, aphasia, right hemiparesis) in a patient on apixaban 4 hours prior, making IV tPA contraindicated per AHA/ASA guidelines. Mechanical thrombectomy without thrombolysis (C) is the uniquely defensible best answer for LVO when tPA is contraindicated. Option A is contraindicated due to recent DOAC use. Option B is not standard practice and still carries hemorrhage risk. Option D (andexanet) is not routinely recommended before thrombectomy unless life-threatening bleeding occurs and would delay reperfusion. Option E (idarucizumab) is specific for dabigatran reversal and ineffective for apixaban. The item is medically accurate and aligns with current stroke guidelines. Minor limitation: the stem does not explicitly confirm LVO with CTA, though NIHSS 18 strongly implies it; specifying 'CTA-confirmed M1 occlusion' would eliminate any ambiguity. No contradictions or underspecification that prevents selecting a single best answer. The teaching point correctly prioritizes rapid reperfusion while respecting anticoagulation contraindications. Overall, a high-quality, board-style item that tests a critical management decision.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-008", "question": "A 3-year-old child with DiGeorge syndrome (22q11.2 deletion) presents with hypocalcemic seizures. Correction of calcium with intravenous calcium gluconate and calcitriol is initiated. Which of the following immunologic parameters, if present, would be an absolute contraindication to live viral vaccination?", "options": ["CD4+ T cell count <500 cells/μL", "Absent thymic shadow on chest radiograph", "Low but detectable T cell receptor excision circles (TRECs)", "Severely reduced proliferative response to phytohemagglutinin", "Complete absence of CD3+ T cells by flow cytometry"], "answer": "E", "answer_index": 4, "explanation": "Complete absence of CD3+ T cells indicates severe combined immunodeficiency (SCID) phenotype within DiGeorge spectrum, which is an absolute contraindication to live vaccines due to risk of disseminated infection. Reduced proliferative responses (option D) indicate functional impairment but not complete absence. Low TRECs suggest poor thymic output but not necessarily SCID. CD4 count and thymic shadow are not definitive contraindications alone.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The item asks which immunologic parameter constitutes an absolute contraindication to live viral vaccination in a 3-year-old with DiGeorge syndrome. Key stem clues are the DiGeorge diagnosis (22q11.2 deletion) and the critical modifier 'absolute contraindication.' Option E (complete absence of CD3+ T cells by flow cytometry) correctly identifies a SCID-like phenotype (complete DiGeorge syndrome), which is unequivocally an absolute contraindication to live vaccines per IDSA/ACIP guidelines due to risk of disseminated infection. Alternative options describe lesser deficits: A (CD4 <500 cells/μL) indicates moderate deficiency but not absolute prohibition; B (absent thymic shadow) and C (low TRECs) reflect poor thymic output without guaranteeing T-cell absence; D (severely reduced PHA proliferation) shows functional impairment but not complete T-cell loss. The hierarchical arrangement of options permits clear discrimination without overlap. No internal contradictions or missing critical details are present. Medical accuracy is excellent: the distinction between partial and complete DiGeorge is well-established, and absolute T-cell absence is the accepted threshold for live vaccine contraindication. No secondary labels apply. Minimal fix: none required; item is board-ready.\",\"medical_accuracy_score\":5,\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The item asks which immunologic parameter constitutes an absolute contraindication to live viral vaccination in a 3-year-old with DiGeorge syndrome. Key stem clues are the DiGeorge diagnosis (22q11.2 deletion) and the critical modifier 'absolute contraindication.' Option E (complete absence of CD3+ T cells by flow cytometry) correctly identifies a SCID-like phenotype (complete DiGeorge syndrome), which is unequivocally an absolute contraindication to live vaccines per IDSA/ACIP guidelines due to risk of disseminated infection. Alternative options describe lesser deficits: A (CD4 <500 cells/μL) indicates moderate deficiency but not absolute prohibition; B (absent thymic shadow) and C (low TRECs) reflect poor thymic output without guaranteeing T-cell absence; D (severely reduced PHA proliferation) shows functional impairment but not complete T-cell loss. The hierarchical arrangement of options permits clear discrimination without overlap. No internal contradictions or missing critical details are present. Medical accuracy is excellent: the distinction between partial and complete DiGeorge is well-established, and absolute T-cell absence is the accepted threshold for live vaccine contraindication. No secondary labels apply. Minimal fix: none required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-009", "question": "A patient with glioblastoma on temozolomide and dexamethasone develops progressive headache, visual changes, and diabetes insipidus. MRI shows thickening and enhancement of the pituitary stalk with loss of the posterior pituitary bright spot. CSF cytology is negative. Which of the following findings would most strongly support a diagnosis of lymphocytic hypophysitis over pituitary metastasis?", "options": ["Presence of anti-pituitary antibodies", "Elevated CSF beta-2 transferrin", "Simultaneous involvement of the pineal gland", "Rapid improvement with high-dose corticosteroids", "Association with other autoimmune endocrine deficiencies"], "answer": "E", "answer_index": 4, "explanation": "Lymphocytic hypophysitis frequently presents with other autoimmune endocrine deficiencies (thyroiditis, adrenalitis, diabetes mellitus type 1), while pituitary metastases typically occur in isolation. Anti-pituitary antibodies have poor sensitivity/specificity. CSF beta-2 transferrin indicates CSF leak. Pineal involvement suggests germinoma. Steroid responsiveness occurs in both conditions but is more dramatic in hypophysitis; however, association with other autoimmune conditions is more specific.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: Correct best answer. Key stem clues—glioblastoma on temozolomide/dexamethasone, pituitary stalk thickening/enhancement, diabetes insipidus, and negative CSF cytology—establish a differential between lymphocytic hypophysitis and pituitary metastasis. The keyed answer E (association with other autoimmune endocrine deficiencies) is uniquely defensible as the most specific discriminator, as this polyendocrine autoimmune pattern is characteristic of hypophysitis and distinctly rare with metastasis. No logical issues: the item is internally consistent, well-specified, and permits clear discrimination. Option A is excluded due to poor antibody sensitivity/specificity; B and C are irrelevant distractors; D lacks specificity since steroid responsiveness occurs in both. Medical accuracy is excellent: the autoimmune polyendocrine association is well-established, and distractors are appropriately flawed. No revision needed.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues—glioblastoma on temozolomide/dexamethasone, pituitary stalk thickening/enhancement, diabetes insipidus, and negative CSF cytology—establish a differential between lymphocytic hypophysitis and pituitary metastasis. The keyed answer E (association with other autoimmune endocrine deficiencies) is uniquely defensible as the most specific discriminator, as this polyendocrine autoimmune pattern is characteristic of hypophysitis and distinctly rare with metastasis. No logical issues: the item is internally consistent, well-specified, and permits clear discrimination. Option A is excluded due to poor antibody sensitivity/specificity; B and C are irrelevant distractors; D lacks specificity since steroid responsiveness occurs in both. Medical accuracy is excellent: the autoimmune polyendocrine association is well-established, and distractors are appropriately flawed. No revision needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-010", "question": "A neonate born at 32 weeks gestation develops necrotizing enterocolitis (NEC) on day 10 of life. During laparotomy, approximately 40% of the small bowel appears necrotic. Which of the following intraoperative findings would mandate creation of a high jejunostomy rather than primary anastomosis?", "options": ["Involvement of the ileocecal valve", "Necrosis extending to within 5 cm of the ligament of Treitz", "Presence of pneumatosis intestinalis in the remaining bowel", "Concurrent isolated perforation of the gastric fundus", "Development of abdominal compartment syndrome during surgery"], "answer": "B", "answer_index": 1, "explanation": "Necrosis extending to within 5 cm of the ligament of Treitz indicates near-total small bowel loss, requiring high jejunostomy to preserve the maximal possible length of viable bowel for future adaptation and prevent anastomotic leakage in compromised tissue. Ileocecal valve involvement is important for absorption but doesn't dictate anastomosis vs ostomy. Pneumatosis may be present in non-necrotic bowel. Gastric perforation is managed separately. Abdominal compartment syndrome may require temporary closure but not necessarily jejunostomy.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). This item tests critical surgical decision-making in severe NEC. Stem clues—32-week prematurity, day 10 onset, 40% small bowel necrosis—frame a high-mortality scenario. The question identifies which finding *mandates* high jejunostomy rather than primary anastomosis. Option B (necrosis extending within 5 cm of the ligament of Treitz) is uniquely defensible: it signifies near-total small bowel loss with insufficient viable proximal bowel for safe anastomosis, compelling proximal diversion to preserve maximal intestinal length and prevent anastomotic dehiscence in compromised tissue. Alternative options are distinctly weaker: ileocecal valve involvement (A) impacts absorptive capacity but not anastomotic strategy; pneumatosis in remaining bowel (C) is not exclusive to necrotic segments; isolated gastric perforation (D) requires separate management; abdominal compartment syndrome (E) may necessitate temporary closure but doesn't dictate stoma type. The keyed answer aligns with established pediatric surgical principles of bowel preservation. No internal contradictions or underspecification. Medical accuracy is sound and board-relevant. Minimal fix: None required.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). This item tests critical surgical decision-making in severe NEC. Stem clues—32-week prematurity, day 10 onset, 40% small bowel necrosis—frame a high-mortality scenario. The question identifies which finding *mandates* high jejunostomy rather than primary anastomosis. Option B (necrosis extending within 5 cm of the ligament of Treitz) is uniquely defensible: it signifies near-total small bowel loss with insufficient viable proximal bowel for safe anastomosis, compelling proximal diversion to preserve maximal intestinal length and prevent anastomotic dehiscence in compromised tissue. Alternative options are distinctly weaker: ileocecal valve involvement (A) impacts absorptive capacity but not anastomotic strategy; pneumatosis in remaining bowel (C) is not exclusive to necrotic segments; isolated gastric perforation (D) requires separate management; abdominal compartment syndrome (E) may necessitate temporary closure but doesn't dictate stoma type. The keyed answer aligns with established pediatric surgical principles of bowel preservation. No internal contradictions or underspecification. Medical accuracy is sound and board-relevant. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]